Literature DB >> 30776730

Clinical and neuroimaging features of the m.10197G>A mtDNA mutation: New case reports and expansion of the phenotype variability.

D Tolomeo1, A Rubegni2, M Severino3, F Pochiero4, C Bruno5, D Cassandrini6, A Madeo7, S Doccini8, M Pedemonte9, A Rossi10, F D'Amore2, M A Donati11, M Di Rocco12, F M Santorelli13, C Nesti2.   

Abstract

Complex I (CI) is the largest component of the mitochondrial respiratory chain (MRC) and it is made up of 7 mitochondrial DNA (mtDNA)-encoded and at least 38 nuclear DNA-encoded subunits. Isolated CI deficiency is the most common single enzyme deficiency in the heterogeneous group of MRC disorders and it is a relatively common etiology of Leigh-like syndrome (LS). With a few exceptions, descriptions of the clinical spectrum of specific mutations in CI are scarce. We here present three unrelated Italian children who harbored the homoplasmic m.10197G>A mutation in MT-ND3 associated with reduced enzyme activity of CI in muscle. Compared with the spectrum of phenotypes seen in 13 previously described families with the same mutation, these children showed some novel clinical features. Two of the boys presented with subacute onset of dystonia, which showed a remitting-relapsing clinical course in one of them. The third boy presented acute symptoms consisting of speech impairment, progressive left-sided hemiparesis, and also vertebral and arterial malformations. In all the children, molecular studies identified a similar mutation load in tissues, and neuroimaging findings were consistent with the features seen in LS. Functional investigations in cultured skin fibroblasts suggested low ATP production in homoplasmic cells. Our results confirm that the m.10197G>A mutation is relevant to these patients' clinical and biochemical phenotypes, which thus expand the array of phenotypes associated with this variant.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complex I deficiency; Leigh syndrome; ND3 gene; mtDNA

Mesh:

Substances:

Year:  2019        PMID: 30776730     DOI: 10.1016/j.jns.2019.02.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Extended spinal cord involvement in adult-onset Leigh syndrome due to mitochondrial 10197G > A mutation.

Authors:  Yanping Wei; Min Qian; Yingmai Yang
Journal:  Neurol Sci       Date:  2022-07-31       Impact factor: 3.830

2.  Next-generation sequencing of Tunisian Leigh syndrome patients reveals novel variations: impact for diagnosis and treatment.

Authors:  Meriem Hechmi; Majida Charif; Ichraf Kraoua; Meriem Fassatoui; Hamza Dallali; Valerie Desquiret-Dumas; Céline Bris; David Goudenège; Cyrine Drissi; Saïd Galaï; Slah Ouerhani; Vincent Procaccio; Patrizia Amati-Bonneau; Sonia Abdelhak; Ilhem Ben Youssef-Turki; Guy Lenaers; Rym Kefi
Journal:  Biosci Rep       Date:  2022-09-30       Impact factor: 3.976

3.  Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases.

Authors:  Chiara Ticci; Daniele Orsucci; Anna Ardissone; Luca Bello; Enrico Bertini; Irene Bonato; Claudio Bruno; Valerio Carelli; Daria Diodato; Stefano Doccini; Maria Alice Donati; Claudia Dosi; Massimiliano Filosto; Chiara Fiorillo; Chiara La Morgia; Costanza Lamperti; Silvia Marchet; Diego Martinelli; Carlo Minetti; Maurizio Moggio; Tiziana Enrica Mongini; Vincenzo Montano; Isabella Moroni; Olimpia Musumeci; Elia Pancheri; Elena Pegoraro; Guido Primiano; Elena Procopio; Anna Rubegni; Roberta Scalise; Monica Sciacco; Serenella Servidei; Gabriele Siciliano; Costanza Simoncini; Deborah Tolomeo; Paola Tonin; Antonio Toscano; Flavia Tubili; Michelangelo Mancuso; Roberta Battini; Filippo Maria Santorelli
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

4.  Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease.

Authors:  Yiqin Wang; Xiaoxian Guo; Kaixiong Ye; Michael Orth; Zhenglong Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.